Mylan
Executive Summary
Licenses generic sustained-release formulation of terfenadine/pseudoephedrine (marketed by Marion Merrell Dow as Seldane-D) from AndaSR, a wholly owned subsidiary of Ft. Lauderdale-based Andrx Corp. MMD's Seldane-D exclusivity expires Aug. 19